Drug Trial Radar · NCT03888105
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
515
Actual
Start
Nov 13, 2019
Primary completion
Jun 17, 2026
Study completion Dec 15, 2028
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Mar 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL). The main purpose of this study is to assess the effectiveness of odronextamab in destroying cancer cells and to learn more about the safety of odronextamab. The study is looking at several other research questions, including: * To see if odronextamab works to destroy cancer cells * Side effects that may be experienced by people taking odronextamab * How odronextamab works in the body * How much odronextamab is present in the blood
Conditions
- B-cell Non-Hodgkin Lymphoma (B-NHL)
Interventions
OdronextamabDrug
Administered by intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR), as assessed by independent central reviewTime frame: Up to 52 weeks of study treatment
- ORR, as assessed by independent central reviewTime frame: Up to 36 weeks of study treatment
Locations
119 sites in 14 countries. Site status is shown where the registry gives one.
Rush University Medical Center
Chicago, Illinois
University of Iowa
Iowa City, Iowa
Norton Cancer Institute
Louisville, Kentucky
Tufts Medical Center
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Mayo Clinic - Rochester
Rochester, Minnesota
John Theurer Cancer Center at Hackensack UMC
Hackensack, New Jersey
Weill Cornell Medical College New York Presbyterian Hospital
New York, New York
Stony Brook University Hospital
Stony Brook, New York
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
Stephenson Cancer Center
Oklahoma City, Oklahoma
Harold C. Simmons Comprehensive Cancer Center
Dallas, Texas
Border Medical Oncology
East Albury, New South Wales, Australia
Northern NSW Local Health District The Tweed Hospital
Tweed Heads, South Wales, Australia
Epworth Hospital
East Melbourne, Victoria, Australia
North Building
Frankston, Victoria, Australia
Andrew Love Cancer Centre
Geelong, Victoria, Australia
Olivia Newton John Cancer Wellness & Research Centre
Heidelberg, Victoria, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Cross Cancer Institute
Edmonton, Alberta, Canada
QEII Health Science Centre - Halifax location
Halifax, Nova Scotia, Canada
Peking University - Third Hospital
Beijing, China
Peking University Cancer Hospital (Beijing Cancer Hospital) (Beijing Institute for Cancer Research)
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Institute of Hematology & Blood Diseases Hospital
Tianjin, Beijing Municipality, China
Second Affiliated Hospital - Xinqiao Hospital
Chongqing, Chongqing Municipality, China
Sun Yat-Sen University Cancer Center - Cancer Prevention and Treatment Center, Sun Yat-sen University
Guangzhou, Guangdong, China
The Affiliated Tumor Hospital
Harbin, Heilongjiang, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
The First Affiliated Hospital - Soochow University
Suzhou, Jiangsu, China
The First Bethune Hospital
Changchun, Jilin, China
The First Affiliated Hospital of Xi 'an Jiaotong University
Xi'an, Shaanxi, China
Shanhai Cancer Center
Shanghai, Shanghai Municipality, China
West China Hospital
Chengdu, Sichuan, China
Tianjin Medical University Cancer Institute
Tianjin, Tianjin Municipality, China
The First Hospital affiliated to the Medical School of Zhejiang University
Hangzhou, Zhejiang, China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Hopital Saint Louis
Paris, France
Showing 40 of 119 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.